PharVision Advisers’s JBS N.V. JBS Stock Holding History

PharVision Advisers’s Portfolio JBS Stock Details JBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-13,601	Closed	-$203K	–	1062
2025 Q3	$203K	Buy	+13,601	New	+$198K	0.11%	503

Other funds holding JBS

BPS

BNDES Participacoes SA Rio De Janeiro, Brazil $2.36B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

AIMCA

Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.56% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PharVision Advisers's JBS Position: Q4 2025 in Review

PharVision Advisers sold out of JBS N.V. (JBS) in Q4 2025, closing a stake of 13,601 shares — an estimated $203K sold.

PharVision Advisers first reported a position in JBS in Q3 2025 and held it in 1 quarter. The position peaked at $203K in Q3 2025. 238 funds tracked by Wall St. Rank hold JBS as of Q4 2025.

PharVision Advisers reported no remaining JBS N.V. position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 13,601 JBS N.V. shares in Q4 2025, an estimated $203K.
PharVision Advisers first reported a position in JBS N.V. in Q3 2025 and held it in 1 quarter.
PharVision Advisers's JBS N.V. position peaked at $203K in Q3 2025.
238 funds tracked by Wall St. Rank held JBS N.V. as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.